Search results
Results from the WOW.Com Content Network
The most common side effects include constipation, muscle pain and edema (swelling) including of the ankles and feet, the face, the eyelids and the area around the eyes. [7] Alectinib was approved for medical use in Japan in 2014, the United States in 2015, Canada in 2016, Australia in 2017, the European Union in 2017, and the United Kingdom in ...
Phi Sigma Pi became co-educational in 1977. [6] [2] Phi Sigma Pi membership is open to students at four-year collegiate institutions who have earned a 3.0 cumulative grade point average (on a 4.00 scale, where 4.00 is equivalent to a grade of "A") for at least one semester or a quarter of collegiate work. Chapters can raise this requirement but ...
In another study, the treatment had positive effects on 4 out of 5 patients with blood cancers, with more than half becoming symptom-free. READ MORE: WHO backs new weapons in Zika fight
The Phi Sigma honor society was founded on March 17, 1915, at Ohio State University to honor excellence in biological research. [ 1 ] [ 2 ] In 1928 its constitution was so altered that the society "should now be considered as a working guild", with a focus on ongoing research.
Infigratinib is currently in clinical trials for the treatment of children with achondroplasia.Infigratinib is now in a Phase 3 clinical trial. [12]Infigratinib was originally developed at a higher dose for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma (bile duct cancer) with a fibroblast growth factor receptor 2 (FGFR2) fusion ...
Nilotinib is used to treat Philadelphia chromosome (Ph+)-positive chronic myelogenous leukaemia. [3] [6] It is indicated for the treatment of newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia in chronic phase; [3] [5] adults with chronic phase and accelerated phase Philadelphia chromosome positive chronic myeloid leukemia resistant to or intolerant to prior therapy that ...
Avapritinib, sold under the brand name Ayvakit among others, is a medication used for the treatment of advanced systemic mastocytosis and indolent systemic mastocytosis. It is also used for the treatment of tumors due to one specific rare mutation: it is specifically intended for adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) that harbor a platelet-derived growth ...
Tucatinib is a kinase inhibitor indicated in combination with trastuzumab and capecitabine for the treatment of adults with advanced unresectable or metastatic HER2-positive breast cancer, including those with brain metastases, who have received one or more prior anti-HER2-based regimens in the metastatic setting.